asciminib: Clinical Trials

2 trials of asciminib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow asciminib: new trials by email Literature Review of asciminib trials Research Report on asciminib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Phase 4CompletedNovartis Pharmaceuticals852024-11-282026-06-08
Asciminib Roll-over Study
Asciminib single agent, Imatinib, Nilotinib - Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Phase 4RecruitingNovartis Pharmaceuticals3472022-08-302026-11-09

Conditions studied

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Blast Crisis (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Myeloproliferative Disorders (1)

Sponsors

Novartis Pharmaceuticals (2)

Countries

Argentina (1)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Malaysia (1)

NIH funding

2023 (1)